This article is more than 5 years old. Information may no longer be current.

VisiJet releases third quarter results

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IRVINE, Calif. — VisiJet reported revenues of $983,000 in the third quarter of 2004, compared with no revenues in the previous year, the company stated in a press release. The increase in revenue was attributed to VisiJet’s sales of its EpiLift System in international markets. The company received U.S. marketing approval for the device in mid-September.

Net loss for the quarter was $1.5 million, about the same as in the same period 1 year ago, the company said.

The EpiLift System is used to separate the epithelium from Bowman’s membrane for epi-LASIK, the company said. The system is currently being marketed in the United States and in more than 20 other countries, including Korea and Japan, according to VisiJet.